Peptide research,
without the fog.
Source-labeled research summaries, protocol context, COA education, and documentation-first industry analysis.
Start with the question you have.
The Index is organized around research context, study reporting, documentation, and market accountability.
Research Overviews
Mechanisms, study designs, and literature context.
Benefits & Uses
What published sources actually discuss.
Reported Protocols
Study details reported by cited sources—not instructions.
COA & Documentation
Identity, purity, batches, and analytical records.
Industry Red Flags
Claims, gaps, and warning signs worth checking.
Research Checklists
Practical documentation-first review tools.
Latest articles
MOTS-C Human Trials and Exercise Studies
A source-labeled review of human and exercise-related MOTS-C research, separated from preclinical evidence.
Semax BDNF and Gene-Expression Research
A focused review of BDNF and gene-expression findings discussed in published Semax research.
Semax Reported Routes, Amounts, and Study Designs
A source-labeled summary of routes, amounts, frequencies, durations, and models reported in Semax studies, provided as literature context only.
Semax Human Studies vs Preclinical Research
A source-labeled separation of human Semax studies from animal, cell, and mechanistic research.
Tesamorelin Mechanism and IGF-1 Findings in Published Studies
A focused literature review of Tesamorelin mechanism and IGF-1 findings reported in cited studies.
Tesamorelin Study Duration, Endpoints, and Reported Outcomes
A source-labeled review of study durations, endpoints, and outcome measurements reported in Tesamorelin trials.
A claim is not documentation.
Peptide Bio Index separates what sources report from what marketing implies. Missing details stay missing. Weak evidence stays labeled.
Read our methodology →